SPARC and neoplasm: Trying to explain the reduced suppressive activities of Sparc−/− MDSC we evaluate ROS expression in total MDSC (CD11b+ fraction, as described in Melani et al. (6) isolated from the spleen of WT and Sparc−/− tumor-bearing mice.